Similarly, higher CSF levels of ICAM-1, interleukin-8, MMP3, SCF and VEGF were associated with higher CSF levels of neurodegenerative/PD-specific biomarkers in the DLB cohort. This evidence concerns the gene CSF2 and Parkinson disease.